AGTR2 and arthritic joint disease: Given the finding that the selective AT2 receptor agonists suppressed local inflammatory cytokines and monocyte migration in animal models of arthritis both in vivo and in vitro studies [85,86,87] (Figure 6), it could be speculated that Ang II produced in joints exacerbates inflammation via AT1 receptors.